Inter-individual variation of inflammatory markers of cardiovascular risks and diseases

Hind Berrahmoune1, John Lamont, Peter Fitzgerald

  • 1INSERM U525 Equipe 4, Faculté de Pharmacie, Université Henri Poincaré Nancy I, Nancy, France.

Insights

Investigating inflammation

Area of Science:

  • Cardiovascular health and inflammation research.

Background:

  • Cardiovascular diseases (CVDs) pose a significant public health challenge due to their complex, multifactorial origins.
  • Understanding CVDs is complicated by their clinical and biological heterogeneity.
  • Examining individual biological systems and their interactions offers a path to comprehending disease development.

Purpose of the Study:

  • To review environmental, genetic, and epigenetic factors influencing inflammation's intermediate phenotypes (protein and RNA levels).
  • To explore a novel approach using intermediate phenotype variation for elucidating complex diseases like CVDs.
  • To identify potential risk markers for predicting and managing cardiovascular disease.

Main Methods:

  • Literature review focusing on determinants of inflammation's intermediate phenotypes.
  • Analysis of studies investigating environmental, genetic, and epigenetic factors in healthy populations.
  • Synthesis of findings on protein and RNA levels as intermediate phenotypes of inflammation.

Main Results:

  • Inflammation is a key factor in the onset and progression of cardiovascular diseases.
  • Environmental, genetic, and epigenetic factors significantly influence intermediate inflammation phenotypes.
  • Studies in healthy populations reveal insights into the regulation of these phenotypes.

Conclusions:

  • Studying intermediate phenotypes of inflammation provides a promising approach to understanding cardiovascular diseases.
  • Identifying determinants of these phenotypes can lead to novel risk markers.
  • This approach may enable personalized treatment strategies for cardiovascular disease patients.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...